Opinion

Video

Closing Thoughts and Key Takeaways on Small Cell Lung Cancer

In a forward-looking discussion, Ticiana Leal, MD; Anne Chiang, MD, PhD; Afshin Dowlati, MD; and Tarita O. Thomas, MD, PhD, offer their concluding insights on the evolving landscape of clinical trials and the future directions of small cell lung cancer (SCLC) treatment, highlighting promising areas of research and potential breakthroughs that may shape the management of this challenging disease in the years to come.

Related Videos
Balazs Halmos, MD
Balazs Halmos, MD
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Suresh Senan, MRCP, FRCR, PhD, full professor, treatment and quality of life, full professor, cancer biology and immunology, full professor, radiation oncology, professor, clinical experimental radiotherapy, Amsterdam University Medical Centers
Alison Schram, MD
Kevin Kalinsky, MD, MS
David Rimm, MD, PhD
Mary B. Beasley, MD, discusses molecular testing challenges in non–small cell lung cancer and pancreatic cancer.